Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Artificial Intelligence in epidemiology industry 360° synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Deployment trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Artificial Intelligence In Epidemiology Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising adoption of artificial intelligence in epidemiology & disease surveillance
3.3.1.2 Potential to increase quality of care delivery
3.3.1.3 Need to curb incremental healthcare costs
3.3.1.4 Advancements in Machine Learning, Deep Learning, and Predictive Analytics
3.3.2 Industry pitfalls & challenges
3.3.2.1 Security concerns regarding patient data
3.3.2.2 Data availability and quality challenges
3.4 Growth potential analysis
3.4.1 By deployment
3.4.2 By application
3.4.3 By end-use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.1.1 Health IT Legislation
3.6.1.2 Health Information Technology for Economic and Clinical Health (HITECH) Act
3.6.1.3 HIPAA
3.6.1.4 Health IT Regulations
3.6.1.5 Common Rule
3.6.1.6 Federal Trade Commission Act (FTCA)
3.6.1.7 FTC Health Breach Notification Rule
3.6.2 Europe
3.6.3 China
3.6.4 Others
3.7 Reimbursement scenario
3.7.1 U.S.
3.7.2 Europe
3.8 Gap analysis
3.9 Start-up scenario
3.10 Investment landscape
3.11 Policy landscape
3.11.1 H-480.940- Augmented Intelligence in Health Care
3.11.2 FDA’s Digital Health Initiative
3.12 Technology landscape
3.13 Application potential
3.13.1 Public health (Disease Surveillance)
3.13.2 Drug Discovery & Development
3.14 Porter's Analysis
3.15 Competitive landscape, 2021
3.15.1 Company matrix analysis, 2021
3.16 PESTLE Analysis
Chapter 4 Artificial Intelligence In Epidemiology Market, By Deployment
4.1 Key segment trends
4.2 Web-based
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Cloud-based
4.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Artificial Intelligence In Epidemiology Market, By Application
5.1 Key segment trends
5.2 Infection Prediction & Forecasting
5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Disease & Syndromic Surveillance
5.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Artificial Intelligence In Epidemiology Market, By End-Use
6.1 Key segment trends
6.2 Government & State Agencies
6.2.1 Market size, by region, 2017 - 2030 (USD Million)
6.3 Research Labs
6.3.1 Market size, by region, 2017 - 2030 (USD Million)
6.4 Pharmaceutical & Biotechnology Companies
6.4.1 Market size, by region, 2017 - 2030 (USD Million)
6.5 Healthcare Providers
6.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Artificial Intelligence In Epidemiology Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2017 - 2030 (USD Million)
7.2.2 Market size, by deployment, 2017 - 2030 (USD Million)
7.2.3 Market size, by application, 2017 - 2030 (USD Million)
7.2.4 Market size, by end-use, 2017 – 2030 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.2.5.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.2.6 Canada
7.2.6.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.2.6.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2017 - 2030 (USD Million)
7.3.2 Market size, by deployment, 2017 - 2030 (USD Million)
7.3.3 Market size, by application, 2017 - 2030 (USD Million)
7.3.4 Market size, by end-use, 2017 – 2030 (USD Million)
7.3.5 Germany
7.3.5.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.5.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.3.6 UK
7.3.6.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.6.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.3.7 France
7.3.7.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.7.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.3.8 Italy
7.3.8.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.8.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.3.9 Spain
7.3.9.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.9.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2017 - 2030 (USD Million)
7.4.2 Market size, by deployment, 2017 - 2030 (USD Million)
7.4.3 Market size, by application, 2017 - 2030 (USD Million)
7.4.4 Market size, by end-use, 2017 – 2030 (USD Million)
7.4.5 China
7.4.5.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.5.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.4.6 Japan
7.4.6.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.6.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.4.7 India
7.4.7.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.7.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.4.8 Australia
7.4.8.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.8.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.4.9 South Korea
7.4.9.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.9.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2017 - 2030 (USD Million)
7.5.2 Market size, by deployment, 2017 - 2030 (USD Million)
7.5.3 Market size, by application, 2017 - 2030 (USD Million)
7.5.4 Market size, by end-use, 2017 – 2030 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.5.5.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.5.6.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.5.7 Argentina
7.5.7.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
7.5.7.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.6 Middle East & Africa
7.6.1 Market size, by country, 2017 - 2030 (USD Million)
7.6.2 Market size, by deployment, 2017 - 2030 (USD Million)
7.6.3 Market size, by application, 2017 - 2030 (USD Million)
7.6.4 Market size, by end-use, 2017 – 2030 (USD Million)
7.6.5 South Africa
7.6.5.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.6.5.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.6.6 Saudi Arabia
7.6.6.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.6.6.3 Market size, by end-use, 2017 – 2030 (USD Million)
7.6.7 UAE
7.6.7.1 Market size, by deployment, 2017 - 2030 (USD Million)
7.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
7.6.7.3 Market size, by end-use, 2017 – 2030 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2021
8.2 Cerner Corporation
8.2.1 Business Overview
8.2.2 Financial Data
8.2.3 Product Landscape
8.2.4 Strategic Outlook
8.2.5 SWOT Analysis
8.3 Cognizant
8.3.1 Business Overview
8.3.2 Financial Data
8.3.3 Product Landscape
8.3.4 Strategic Outlook
8.3.5 SWOT Analysis
8.4 eClinicalWorks, Inc.
8.4.1 Business Overview
8.4.2 Financial Data
8.4.3 Product Landscape
8.4.4 Strategic Outlook
8.4.5 SWOT Analysis
8.5 Epic Systems Corporation
8.5.1 Business Overview
8.5.2 Financial Data
8.5.3 Product Landscape
8.5.4 Strategic Outlook
8.5.5 SWOT Analysis
8.6 Alphabet, Inc.
8.6.1 Business Overview
8.6.2 Financial Data
8.6.3 Product Landscape
8.6.4 Strategic Outlook
8.6.5 SWOT Analysis
8.7 Intel Corporation
8.7.1 Business Overview
8.7.2 Financial Data
8.7.3 Product Landscape
8.7.4 Strategic Outlook
8.7.5 SWOT Analysis
8.8 Microsoft Corporation
8.8.1 Business Overview
8.8.2 Financial Data
8.8.3 Product Landscape
8.8.4 Strategic Outlook
8.8.5 SWOT Analysis
8.9 Meditech
8.9.1 Business Overview
8.9.2 Financial Data
8.9.3 Product Landscape
8.9.4 Strategic Outlook
8.9.5 SWOT Analysis
8.10 Predixion Healthcare (Jvion LLC)
8.10.1 Business Overview
8.10.2 Financial Data
8.10.3 Product Landscape
8.10.4 Strategic Outlook
8.10.5 SWOT Analysis
8.11 Komodo Health
8.11.1 Business Overview
8.11.2 Financial Data
8.11.3 Product Landscape
8.11.4 Strategic Outlook
8.11.5 SWOT Analysis
8.12 Siemens Healthineers
8.12.1 Business Overview
8.12.2 Financial Data
8.12.3 Product Landscape
8.12.4 Strategic Outlook
8.12.5 SWOT Analysis
8.13 Bayer Healthcare
8.13.1 Business Overview
8.13.2 Financial Data
8.13.3 Product Landscape
8.13.4 Strategic Outlook
8.13.5 SWOT Analysis
8.14 Cardiolyse
8.14.1 Business Overview
8.14.2 Financial Data
8.14.3 Product Landscape
8.14.4 Strategic Outlook
8.14.5 SWOT Analysis
8.15 Artificial Intelligence in Medical Epidemiology (AIME)
8.15.1 Business Overview
8.15.2 Financial Data
8.15.3 Product Landscape
8.15.4 Strategic Outlook
8.15.5 SWOT Analysis
8.16 SAS Institute
8.16.1 Business Overview
8.16.2 Financial Data
8.16.3 Product Landscape
8.16.4 Strategic Outlook
8.16.5 SWOT Analysis
